Results 31 to 40 of about 25,229,305 (191)

Nodular scleritis as the eye manifestation in Behcet′s syndrome

open access: yesOman Journal of Ophthalmology, 2015
We report a case of a 45-year-old female, who was diagnosed as Behcet′s disease and presented to us with nodular scleritis in her right eye.
Karpagam Damodaran   +2 more
doaj   +1 more source

Exome Sequencing Uncovers Phenotypic and Genotypic Heterogeneity in 196 Indian Families Evaluated for Autoinflammatory Disorders

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Autoinflammatory disorders (AIDs) are a clinically heterogeneous group of inborn errors of immunity primarily caused by dysregulation in the innate immune system. Clinical diagnosis is often challenging due to clinical heterogeneity and the overlapping phenotypes with other inborn errors of immunity and monogenic conditions that mimic AIDs ...
Vaishnavi Ashok Badiger   +28 more
wiley   +1 more source

Histopathologic study of pathergy test in behçet′s disease

open access: yesIndian Journal of Dermatology, 2014
Background: The pathergy test (PT) is important in the diagnosis of Behçet′s disease (BD). However, misinterpretation of the test might cause false-positive or false-negative results.
Ekin Ozluk   +6 more
doaj   +1 more source

Higher Complement C4 Gene Copy Number Constitutes a Shared Genetic Risk Factor for Giant Cell Arteritis and IgA Vasculitis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Low copy number (CN) of complement C4 isoforms and high CN of retroviral HERV‐K elements are known risk factors for many immune‐mediated inflammatory diseases (IMIDs), often showing sex‐biased effects. Here, we assessed whether CN variation within the C4 gene contributes to giant cell arteritis (GCA) and IgA vasculitis (IgAV), two complex ...
Laura Martínez‐Gutiérrez   +295 more
wiley   +1 more source

Fractalkine (CX3CL1) levels in patients with Behcet's disease and Neuro-Behcet's disease

open access: yes, 2012
Objective: The aim of the present study was to assess the role of CX3CL1 in patients with active and inactive Behcet's Disease (BD), Neuro-Behcet's Disease (NBD) and control subjects.
Fidan, Işıl   +7 more
core   +1 more source

Updated COVID‐19 Vaccines and Health Outcomes in Patients With Autoimmune Rheumatic Conditions

open access: yesArthritis &Rheumatology, EarlyView.
Objective We aimed to assess the association between COVID‐19 vaccination status and COVID‐19‐related hospital admissions, need for mechanical ventilation or extracorporeal membrane oxygenation (ECMO), and death in people with autoimmune rheumatic conditions. Methods We conducted a retrospective cohort study using National Clinical Cohort Collaborative
Lesley E. Jackson   +127 more
wiley   +1 more source

Experimental Therapeutic Solutions for Behcet’s Disease

open access: yesJournal of Experimental Pharmacology, 2021
Burçin Cansu Bozca, Erkan Alpsoy Akdeniz University School of Medicine, Department of Dermatology and Venereology, Antalya, TurkeyCorrespondence: Erkan AlpsoyAkdeniz University School of Medicine, Department of Dermatology and Venereology, Antalya,
Bozca BC, Alpsoy E
doaj  

Increased CD4(+)CD16(+) and CD4(+)CD56(+) T cell subsets in Behcet's disease

open access: yes, 1999
Behcet's disease is a systemic vasculitis of unknown etiology. Various immune abnormalities have previously been shown in Behcet's disease. We investigated T lymphocyte subsets associated with cytotoxic activity and natural killer (NK) cells by
DİRESKENELİ, RAFİ HANER   +1 more
core   +1 more source

Endovascular repair of a dual abdominal aortic aneurysm in Behcet's disease

open access: yesTurkish Journal of Vascular Surgery, 2019
Behcet's disease is an inflammatory multisystemic vasculitis characterized by orogenic ulcers and ocular lesions and its etiology is still unknown. The incidence of aortic aneurysms is 2 to 6% in patients with Behcet's disease and 18% of these ...
Elif Coşkun   +3 more
doaj  

Complement Activation Linked to Type II Interferon Signaling in Still Disease

open access: yesArthritis &Rheumatology, EarlyView.
Objective Still disease (SD) is an autoinflammatory syndrome characterized by innate immune dysregulation. Although complement can drive inflammation, its involvement in SD remains to be defined. Thus, we aimed to assess complement activation in SD. Methods Complement was assessed using transcriptomic, proteomic, and in vitro approaches. RNA sequencing
Freya M. C. H. Huijsmans   +115 more
wiley   +1 more source

Home - About - Disclaimer - Privacy